Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota

The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated w...

Full description

Bibliographic Details
Main Authors: M. S. Eliseev, E. N. Kharlamova, O. V. Zhelyabina, A. M. Lila
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-12-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1366
_version_ 1797876652820135936
author M. S. Eliseev
E. N. Kharlamova
O. V. Zhelyabina
A. M. Lila
author_facet M. S. Eliseev
E. N. Kharlamova
O. V. Zhelyabina
A. M. Lila
author_sort M. S. Eliseev
collection DOAJ
description The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized.
first_indexed 2024-04-10T02:05:06Z
format Article
id doaj.art-2e32cb6a1e1a46e58d8c50f3b0c8d7b0
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2024-04-10T02:05:06Z
publishDate 2022-12-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-2e32cb6a1e1a46e58d8c50f3b0c8d7b02023-03-13T08:39:30ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2022-12-0116671110.14412/1996-7012-2022-6-7-112531Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiotaM. S. Eliseev0E. N. Kharlamova1O. V. Zhelyabina2A. M. Lila3Научно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. Насоновой; Российская медицинская академия непрерывного профессионального образования Минздрава РоссииThe article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized.https://mrj.ima-press.net/mrj/article/view/1366микробиотаподаграгиперурикемияпробиотикипребиотикифебуксостаталлопуринол
spellingShingle M. S. Eliseev
E. N. Kharlamova
O. V. Zhelyabina
A. M. Lila
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
Современная ревматология
микробиота
подагра
гиперурикемия
пробиотики
пребиотики
фебуксостат
аллопуринол
title Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
title_full Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
title_fullStr Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
title_full_unstemmed Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
title_short Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
title_sort microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout part 2 gout therapy and the gut microbiota
topic микробиота
подагра
гиперурикемия
пробиотики
пребиотики
фебуксостат
аллопуринол
url https://mrj.ima-press.net/mrj/article/view/1366
work_keys_str_mv AT mseliseev microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota
AT enkharlamova microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota
AT ovzhelyabina microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota
AT amlila microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota